New agreement signed
A collaboration Agreement with a chinese partner was signed for introducing AgeViva as a antiaging food supplement product in China. The work with the inlicensing in China have already started after the signing of the contract January 13.
New production is being produced by Jästbolaget
A new production of our patented yeast is being produced by Jästbolaget ahead of the launch of our patented anti-aging product AgeViva™ in Q1 2025.
New trademark is approved
Our trademark AgeViva™ was approved Nov 29.
Visit to Sapienza University
Trevor Archer, Thomas Lenz and Roger Karlsson visited Sapienza University Nov 25-28. The team at Sapienza with professor Rita Businaro presented new results in antiaging studies. The presentation showed new very positive and strong study results for the important hallmarks of longevity/antiaging: autophagy, anti-inflammageing and anti-oxidative stress
30th annual BIO-Europe
Trevor Archer and Thomas Lenz, has participated in the 30th annual which took place this year in Stockholm November 4-6. BIO-Europé is one of the top pharma events in Europe. The BIO-Europe program explores the impact of the Swedish approach, embodied by an openness to collaboration, has had on biotech innovation, and addresses the latest… Read More »30th annual BIO-Europe
New subsidiary Longevience AB is registred.
Milmed Unico’s new subsidiary Longevience AB is registred the 11th of October. Everything related to longevity and antiaging will be in our new company.